| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 | Dec, 2018 |
| Sales | 3,629,040 | 3,226,410 | 2,200,430 | 1,300,030 | 1,207,570 |
| Sales Growth | +12.48% | +46.63% | +69.26% | +7.66% | +14.33% |
| Net Income | 521,480 | 534,490 | 389,800 | 573,020 | -74,190 |
| Net Income Growth | -2.43% | +37.12% | -31.97% | +872.37% | +81.93% |
Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.
Fiscal Year End Date: 12/31